Hongyan Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hongyan Deng has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Xinhua Ye
Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
4 shared publications Liuxi Wu
3 shared publicationsHua Shu
Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publicationsWenjuan Lu
Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publicationsWenqin Chen
Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publicationsYa Yuan
Department of Ultrasound, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 shared publications
Latest Publications
- Open Access
- 1 March 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (3) , 69
Development and validation of an ultrasound-based radiomics nomogram for predicting metastatic central cervical lymph nodes in clinically lymph node-negative patients with papillary thyroid microcarcinoma
Background: The rate of cervical central lymph node metastasis (CLNM) in papillary thyroid microcarcinoma (PTMC) patients is relatively high. It is controversial that patients with clinically lymph node (LN)-negative entail prophylactic central neck dissection (pCND). The objective of this study was to develop and validate a predictive nomogram incorporating both radiomics signatures and ultrasonic features to aid in the individualized, preoperative assessment of central cervical LN metastasis in patients with clinically node-negative PTMC. Methods: A total of 266 patients, each with a single malignant thyroid nodule, were enrolled and randomly split into a training set and a validation set at a ratio of 7:3. Radiomics signatures were constructed by applying the least absolute shrinkage and selection operator (LASSO) regression to features extracted from two-dimensional (2D) ultrasound (US) images. We then built three logistic regression models using clinical and US features (model 1), the radiomics signatures (model 2), and a combination of both (model 3). Finally, we presented the combined model as a nomogram and assessed its clinical utility with decision curve analysis (DCA). Results: The highest diagnostic performance was achieved by model 3, which showed robust discrimination in the training [area under the curve (AUC) =0.892], internal validation (AUC =0.772), and external validation (AUC =0.842) sets, outperforming model 1 and model 2. Conclusions: A nomogram combining radiomics analysis based on US images of PTMC with clinical and imaging features showed a better diagnostic performance than conventional US imaging features alone in predicting metastatic central cervical LNs preoperatively in clinically LN-negative patients with PTMC and could assist in making advice associated with treatment plan.
- 1 March 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (3) , 69
Open AccessDevelopment and validation of an ultrasound-based radiomics nomogram for predicting metastatic central cervical lymph nodes in clinically lymph node-negative patients with papillary thyroid microcarcinoma
Background: The rate of cervical central lymph node metastasis (CLNM) in papillary thyroid microcarcinoma (PTMC) patients is relatively high. It is controversial that patients with clinically lymph node (LN)-negative entail prophylactic central neck dissection (pCND). The objective of this study was to develop and validate a predictive nomogram incorporating both radiomics signatures and ultrasonic features to aid in the individualized, preoperative assessment of central cervical LN metastasis in patients with clinically node-negative PTMC. Methods: A total of 266 patients, each with a single malignant thyroid nodule, were enrolled and randomly split into a training set and a validation set at a ratio of 7:3. Radiomics signatures were constructed by applying the least absolute shrinkage and selection operator (LASSO) regression to features extracted from two-dimensional (2D) ultrasound (US) images. We then built three logistic regression models using clinical and US features (model 1), the radiomics signatures (model 2), and a combination of both (model 3). Finally, we presented the combined model as a nomogram and assessed its clinical utility with decision curve analysis (DCA). Results: The highest diagnostic performance was achieved by model 3, which showed robust discrimination in the training [area under the curve (AUC) =0.892], internal validation (AUC =0.772), and external validation (AUC =0.842) sets, outperforming model 1 and model 2. Conclusions: A nomogram combining radiomics analysis based on US images of PTMC with clinical and imaging features showed a better diagnostic performance than conventional US imaging features alone in predicting metastatic central cervical LNs preoperatively in clinically LN-negative patients with PTMC and could assist in making advice associated with treatment plan.
- Open Access
- 10 May 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1354288
Application of ultrasound elastography and radiomic for predicting central cervical lymph node metastasis in papillary thyroid microcarcinoma
Objective: This study aims to combine ultrasound (US) elastography (USE) and radiomic to predict central cervical lymph node metastasis (CLNM) in patients with papillary thyroid microcarcinoma (PTMC).Methods: A total of 204 patients with 204 thyroid nodules who were confirmed with PTMC and treated in our hospital were enrolled and randomly assigned to the training set (n = 142) and the validation set (n = 62). US features, USE (gender, shape, echogenic foci, thyroid imaging reporting and data system (TIRADS) category, and elasticity score), and radiomic signature were employed to build three models. A nomogram was plotted for the combined model, and decision curve analysis was applied for clinical use.Results: The combined model (USE and radiomic) showed optimal diagnostic performance in both training (AUC = 0.868) and validation sets (AUC = 0.857), outperforming other models.Conclusion: The combined model based on USE and radiomic showed a superior performance in the prediction of CLNM of patients with PTMC, covering the shortage of low specificity of conventional US in detecting CLNM.
- 10 May 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1354288
Open AccessApplication of ultrasound elastography and radiomic for predicting central cervical lymph node metastasis in papillary thyroid microcarcinoma
Objective: This study aims to combine ultrasound (US) elastography (USE) and radiomic to predict central cervical lymph node metastasis (CLNM) in patients with papillary thyroid microcarcinoma (PTMC).Methods: A total of 204 patients with 204 thyroid nodules who were confirmed with PTMC and treated in our hospital were enrolled and randomly assigned to the training set (n = 142) and the validation set (n = 62). US features, USE (gender, shape, echogenic foci, thyroid imaging reporting and data system (TIRADS) category, and elasticity score), and radiomic signature were employed to build three models. A nomogram was plotted for the combined model, and decision curve analysis was applied for clinical use.Results: The combined model (USE and radiomic) showed optimal diagnostic performance in both training (AUC = 0.868) and validation sets (AUC = 0.857), outperforming other models.Conclusion: The combined model based on USE and radiomic showed a superior performance in the prediction of CLNM of patients with PTMC, covering the shortage of low specificity of conventional US in detecting CLNM.
- Open Access
- 27 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-11
A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images
The purpose of this paper was to assess the value of ultrasonography in the prognosis of diffuse large b-cell lymphoma (DLBCL) by developing a new prognostic model. One hundred and eleven DLBCL patients with complete clinical information and ultrasound findings were enrolled in our study. Univariate and multivariate regression analyses were used to identify independent risk factors for progression-free survival (PFS) and overall survival (OS). Receiver operator characteristic (ROC) curves were plotted and the corresponding area under the curve (AUC) was calculated to assess the accuracy of the international prognostic index (IPI) and new model in DLBCL risk stratification. The results suggested that hilum loss and ineffective treatment were independent risk variables for both PFS and OS in DLBCL patients. Additionally, the new model that added hilum loss and ineffective treatment to IPI had a better AUC for PFS and OS than IPI alone (AUC: 0.90, 0.88, and 0.82 vs. 0.71, 0.74, and 0.68 for 1-, 3-, and 5-year PFS, respectively; AUC: 0.92, 0.85 and 0.86 vs. 0.71, 0.75 and 0.76, for 1-, 3-, and 5-year OS, respectively). The model based on ultrasound images could better suggest PFS and OS of DLBCL, allowing for better risk stratification.
- 27 February 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-11
Open AccessA model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images
The purpose of this paper was to assess the value of ultrasonography in the prognosis of diffuse large b-cell lymphoma (DLBCL) by developing a new prognostic model. One hundred and eleven DLBCL patients with complete clinical information and ultrasound findings were enrolled in our study. Univariate and multivariate regression analyses were used to identify independent risk factors for progression-free survival (PFS) and overall survival (OS). Receiver operator characteristic (ROC) curves were plotted and the corresponding area under the curve (AUC) was calculated to assess the accuracy of the international prognostic index (IPI) and new model in DLBCL risk stratification. The results suggested that hilum loss and ineffective treatment were independent risk variables for both PFS and OS in DLBCL patients. Additionally, the new model that added hilum loss and ineffective treatment to IPI had a better AUC for PFS and OS than IPI alone (AUC: 0.90, 0.88, and 0.82 vs. 0.71, 0.74, and 0.68 for 1-, 3-, and 5-year PFS, respectively; AUC: 0.92, 0.85 and 0.86 vs. 0.71, 0.75 and 0.76, for 1-, 3-, and 5-year OS, respectively). The model based on ultrasound images could better suggest PFS and OS of DLBCL, allowing for better risk stratification.
- Open Access
- 8 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Diagnostic value of thyroid imaging reporting and data system combined with BRAFV600E mutation analysis in Bethesda categories III–V thyroid nodules
Fine needle aspiration biopsy is a crucial method for preoperative diagnosis of thyroid nodules. However, thyroid nodules classified as Bethesda categories III–V cannot obtain definite cytological results. Our aim was to study the diagnostic value of thyroid imaging reporting and data system combined with BRAFV600E mutation analysis in Bethesda categories III–V thyroid nodules, so as to provide more precise direction for the follow-up treatments. A total of 174 Bethesda categories III–V thyroid nodules performed TIRADS and BRAFV600E mutation analysis were included in the study. We retrospectively analyzed the ultrasound features as well as the results of BRAFV600E mutation of the 174 thyroid nodules. In the multiple regression analysis models, ultrasound features including lobulated or irregular margin, punctate echogenic foci, and shape with taller-than-wide were statistically significant in malignant nodules (p < 0.05). The area under the curve of the combination of TIRADS and BRAFV600E increased to 0.925, which were much higher than TIRADS (0.861) and BRAFV600E (0.804) separately. Combined diagnosis was of the greatest value to identify Bethesda III–V thyroid nodules definitely, especially with higher sensitivity (93%) and accuracy (90%).
- 8 April 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Open AccessDiagnostic value of thyroid imaging reporting and data system combined with BRAFV600E mutation analysis in Bethesda categories III–V thyroid nodules
Fine needle aspiration biopsy is a crucial method for preoperative diagnosis of thyroid nodules. However, thyroid nodules classified as Bethesda categories III–V cannot obtain definite cytological results. Our aim was to study the diagnostic value of thyroid imaging reporting and data system combined with BRAFV600E mutation analysis in Bethesda categories III–V thyroid nodules, so as to provide more precise direction for the follow-up treatments. A total of 174 Bethesda categories III–V thyroid nodules performed TIRADS and BRAFV600E mutation analysis were included in the study. We retrospectively analyzed the ultrasound features as well as the results of BRAFV600E mutation of the 174 thyroid nodules. In the multiple regression analysis models, ultrasound features including lobulated or irregular margin, punctate echogenic foci, and shape with taller-than-wide were statistically significant in malignant nodules (p < 0.05). The area under the curve of the combination of TIRADS and BRAFV600E increased to 0.925, which were much higher than TIRADS (0.861) and BRAFV600E (0.804) separately. Combined diagnosis was of the greatest value to identify Bethesda III–V thyroid nodules definitely, especially with higher sensitivity (93%) and accuracy (90%).